EliotTSNotes Towards the Definition of Culture.London: Faber & Faber, London: 1948.
2.
SnowCPThe Two Cultures.London: Cambridge University Press,1964.
3.
NewmanJHThe Idea of a University: Defined and Illustrated. New Impression. London: Longmans, Green, 1925.
4.
ArnoldMCulture and Anarchy: An Essay in Political and Social Criticism.London: Smith Elder,1869.
5.
SwalesJDThe Growth of Medical Science: The Lessons of Malthus. The Harveian Oration of 1995. London: Royal College of Physicians, 1995.
6.
GordonRD, StowasserM, KlemmSA, TunnyTJ. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: SwalesJD ed. Textbook of Hypertension.Oxford: Blackwell Scientific,1994.
7.
SackettD.Basic research, clinical research, clinical epidemiology and general internal medicine.J Gen Intern Med1987; 2: 40–7.
8.
GarayRP, ElghoziJL, DagherG, MeyerP.Laboratory distinction between essential and secondary hypertension by measurement of erythrocyte cation fluxes.N Engl J Med1980; 302: 769–71.
9.
The Consensus Trial Study Group.Effects of enalapril on mortality in severe heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).N Engl J Med1987; 316: 1629–35.
10.
KleberFX. The economics of cardiac failure.J R Soc Med1996; 89: 9–l2.
11.
ClarkeKW, GrayD, HamptomJR. Evidence of inadequate investigation and treatment of patients with heart failure.Br Heart J1994; 71: 584–7.
12.
CohnJN, BristowMR, ChienKRReport of the National Heart, Lung and Blood Institute Special Emphasis panel on Heart Failure Research.Circulation1997; 95: 766–70.
13.
FlexnerAMedical Education in Europe. Report to the Carnegie Foundation for the Advancement of Learning.New York: Carnegie Foundation,1912.
14.
McNeilBJ, WeichselbaumR, PaukerSG. Fallacy of the five-year survival in lung cancer.N Engl J Med1978; 299: 1397–1401.
15.
SweeneyKG, Pereira GrayD, SteeleR, EvansP.Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.Br J Gen Practice1995; 45: 153–8.
16.
GiardielloFM, BrensingerJD, PetersenGMThe use and interpretation of commercial apc gene testing for familial adenomatous polyposis.N Engl J Med1997; 336: 823–7.
17.
NHS Centre for Reviews and Dissemination, University of York. Preventing and reducing adverse effects of unintended teenage pregnancies.Effective Health Care Bull1997; 3(1).
18.
UbelPA, De KayML, BaronJ, AschDA. Cost-effectiveness analysis in a setting of budget constraints: is it equitable?N Engl J Med1996; 334: 1174–7.
19.
MaynardA.Evidence-based medicine: an incomplete method for informing treatment choices.Lancet1997; 349: 126–8.
20.
HaqIU, RamsayLE, PickinDM, YeoWW, JacksonPR, PayneJN. Lipid-lowering for prevention of coronary heart disease: what policy now?Clin Sci1996; 91: 399–413.
21.
RedelmeierDA, TverskyA.Discrepancy between medical decisions for individual patients and for groups.N Engl J Med1990; 322: 1162–4.
22.
AschDA, UbelPA. Rationing by any other name.N Engl J Med1997; 336: 1668–71.
23.
Howden-ChapmanP, CarterJ, WoodsN.‘Blood money’: blood donors attitudes to changes in the New Zealand blood transfusion service.BMJ1996; 312: 1131–2.
24.
TitmussRMThe Gift Relationship: From Human Blood to Social PolicyOakleyA, AshtonJ, eds. London: LSE Books, 1997.
25.
KleinR.The NHS and the new scientism: solution or delusion?Q J Med1996; 336: 332–6.
26.
BenedictRPatterns of Culture.Boston: Houghton Mifflin,1934.
27.
SchellingTC. The life you save may be your own. In: ChaseS.B.Jr. ed. Problems in Public Expenditure Analysis.Washington, DC: Brookings Institute,1968.